These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28975603)

  • 1. Identifying a candidate population for ovarian conservation in young women with clinical stage IB-IIB cervical cancer.
    Matsuo K; Shimada M; Yamaguchi S; Kanao H; Nakanishi T; Saito T; Kamiura S; Iwata T; Mikami M; Sugiyama T
    Int J Cancer; 2018 Mar; 142(5):1022-1032. PubMed ID: 28975603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of ovarian preservation in women with stage I and II cervical adenocarcinoma: a retrospective study and meta-analysis.
    Chen J; Wang R; Zhang B; Lin X; Wei J; Jia Y; Yin Y; Ye S; Zhu T; Chen G; Yuan Y; Lu W; Li K
    Am J Obstet Gynecol; 2016 Oct; 215(4):460.e1-460.e13. PubMed ID: 27133009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors for pathological parametrial invasion in clinical stage IIB cervical cancer.
    Matsuo K; Shimada M; Nakamura K; Takei Y; Ushijima K; Sumi T; Ohara T; Yahata H; Mikami M; Sugiyama T
    Eur J Surg Oncol; 2019 Aug; 45(8):1417-1424. PubMed ID: 30846298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk stratification models for para-aortic lymph node metastasis and recurrence in stage IB-IIB cervical cancer.
    Matsuo K; Shimada M; Saito T; Takehara K; Tokunaga H; Watanabe Y; Todo Y; Morishige KI; Mikami M; Sugiyama T
    J Gynecol Oncol; 2018 Jan; 29(1):e11. PubMed ID: 29185269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian metastasis in carcinoma of the uterine cervix.
    Shimada M; Kigawa J; Nishimura R; Yamaguchi S; Kuzuya K; Nakanishi T; Suzuki M; Kita T; Iwasaka T; Terakawa N
    Gynecol Oncol; 2006 May; 101(2):234-7. PubMed ID: 16300819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian Conservation and Overall Survival in Young Women With Early-Stage Cervical Cancer.
    Matsuo K; Machida H; Shoupe D; Melamed A; Muderspach LI; Roman LD; Wright JD
    Obstet Gynecol; 2017 Jan; 129(1):139-151. PubMed ID: 27926642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can pelvic lymphadenectomy be omitted in stage IA2 to IIB uterine cervical cancer?
    Togami S; Kamio M; Yanazume S; Yoshinaga M; Douchi T
    Int J Gynecol Cancer; 2014 Jul; 24(6):1072-6. PubMed ID: 24905616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian metastasis in stage IB and II cervical adenocarcinoma.
    Natsume N; Aoki Y; Kase H; Kashima K; Sugaya S; Tanaka K
    Gynecol Oncol; 1999 Aug; 74(2):255-8. PubMed ID: 10419741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent risk factors for ovarian metastases in stage IA-IIB cervical carcinoma.
    Zhou L; Sun CT; Lin L; Xie Y; Huang Y; Li Q; Liu X
    Acta Obstet Gynecol Scand; 2019 Jan; 98(1):18-23. PubMed ID: 30129170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy.
    Takeda N; Sakuragi N; Takeda M; Okamoto K; Kuwabara M; Negishi H; Oikawa M; Yamamoto R; Yamada H; Fujimoto S
    Acta Obstet Gynecol Scand; 2002 Dec; 81(12):1144-51. PubMed ID: 12519111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Ovarian Preservation Feasible in Early-Stage Adenocarcinoma of the Cervix?
    Lu H; Li J; Wang L; Zhou H; Liu Y; Wang D; Lin Z
    Med Sci Monit; 2016 Feb; 22():408-14. PubMed ID: 26852916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should ovaries be removed or not in early-stage cervical adenocarcinoma: a multicenter retrospective study of 105 patients.
    Hu J; Jiao X; Yang Z; Cui H; Guo H; Wu Y; Zhu L
    J Obstet Gynaecol; 2017 Nov; 37(8):1065-1069. PubMed ID: 28631536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of adjuvant therapy for node-positive clinical stage IB-IIB cervical cancer: Systemic chemotherapy versus pelvic irradiation.
    Matsuo K; Shimada M; Aoki Y; Sakamoto M; Takeshima N; Fujiwara H; Matsumoto T; Mikami M; Sugiyama T
    Int J Cancer; 2017 Sep; 141(5):1042-1051. PubMed ID: 28524247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and prognosis of IB-IIB cervical carcinoma with common iliac lymph node metastasis.
    Huang L; Zheng M; Liu JH; Xiong Y; Ding H; Tang L; Wang HY
    Chin J Cancer; 2010 Apr; 29(4):431-5. PubMed ID: 20346221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphovascular and perineural invasion in the parametria: a prognostic factor for early-stage cervical cancer.
    Memarzadeh S; Natarajan S; Dandade DP; Ostrzega N; Saber PA; Busuttil A; Lentz SE; Berek JS
    Obstet Gynecol; 2003 Sep; 102(3):612-9. PubMed ID: 12962952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of ovarian recurrence after ovarian conservation in early-stage cervical cancer treated with radical surgery: A propensity match analysis.
    Bizzarri N; Pedone Anchora L; Kucukmetin A; Ratnavelu N; Korompelis P; Fedele C; Bruno M; Di Fiore GLM; Fagotti A; Fanfani F; Scambia G; Ferrandina G
    Eur J Surg Oncol; 2021 Aug; 47(8):2158-2165. PubMed ID: 33895023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of criteria for ovarian preservation in cervical cancer patients treated with radical surgery with or without neoadjuvant chemotherapy: a multicenter retrospective study and meta-analysis.
    Hu T; Wu L; Xing H; Yang R; Li X; Huang K; Jia Y; Zhang Q; Chen Z; Wang S; Liu D; Han X; Lin Z; Qu P; Cai H; Song X; Tian X; Wang H; Wang S; Xie X; Li S; Ma D
    Ann Surg Oncol; 2013 Mar; 20(3):881-90. PubMed ID: 23054110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and pathological factors related to the prognosis of chinese patients with stage Ib to IIb cervical cancer.
    Xie XZ; Song K; Cui B; Jiang J; Zhang YZ; Wang B; Yang XS; Kong BH
    Asian Pac J Cancer Prev; 2012; 13(11):5505-10. PubMed ID: 23317208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in stage IB-IIB cervical adenocarcinoma patients treated with radical hysterectomy and pelvic lymphadenectomy.
    Kodama J; Seki N; Masahiro S; Kusumoto T; Nakamura K; Hongo A; Hiramatsu Y
    J Surg Oncol; 2010 Apr; 101(5):413-7. PubMed ID: 20127891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of metachronous ovarian cancer after ovarian conservation in young women with stage I cervical cancer.
    Matsuo K; Machida H; Horowitz MP; Shahzad MMK; Guntupalli SR; Roman LD; Wright JD
    Am J Obstet Gynecol; 2017 Nov; 217(5):580.e1-580.e10. PubMed ID: 28666700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.